Publisher's Synopsis
Nine articles explore how pharmacoeconomics is currently used in different settings and how its role will expand in the near term, in order to demonstrate that outcomes are an integral part of assessing the costs and consequences of health care interventions including pharmaceutical therapy. Formulary decision makers, quality management professiona